Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 30, 2014 16:02 ET | Source: TriVascular Technologies, Inc.

TriVascular Technologies, Inc. to Present at the J.P. Morgan 33rd Annual Healthcare Conference

SANTA ROSA, Calif., Dec. 30, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), manufacturer of the Ovation Prime® Abdominal Stent Graft System, today announced that its...
November 10, 2014 16:02 ET | Source: TriVascular Technologies, Inc.

TriVascular Technologies, Inc. Reports Third Quarter 2014 Financial Results

SANTA ROSA, Calif., Nov. 10, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) today reported financial results for the three and nine months ended September 30, 2014. Recent...
November 10, 2014 16:01 ET | Source: TriVascular Technologies, Inc.

TriVascular Technologies, Inc. and CRG LP Amend and Restate Term Loan Facility

SANTA ROSA, Calif., Nov. 10, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) and CRG LP (formerly known as Capital Royalty) and its affiliate funds ("CRG") today announced that...
October 29, 2014 16:02 ET | Source: TriVascular Technologies, Inc.

TriVascular Technologies, Inc. to Participate in Upcoming Investor Conferences

SANTA ROSA, Calif., Oct. 29, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), manufacturer of the Ovation Prime® Abdominal Stent Graft System, today announced the Company...
October 27, 2014 06:00 ET | Source: TriVascular Technologies, Inc.

TriVascular Announces First Patient Enrollment in the LIFE (Least Invasive Fast-Track EVAR) Study

SANTA ROSA, Calif., Oct. 27, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) announced today the first patient enrollment in the LIFE Study, a multi-center post-market registry....
October 20, 2014 16:01 ET | Source: TriVascular Technologies, Inc.

TriVascular Technologies, Inc. to Hold 2014 Third Quarter Financial Results Conference Call on November 10

SANTA ROSA, Calif., Oct. 20, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) today announced that the Company will release 2014 third quarter financial results after market close...
October 15, 2014 06:00 ET | Source: TriVascular Technologies, Inc.

TriVascular Announces FDA Approval of CustomSeal(TM) Technology for the Ovation Prime(R) System

SANTA ROSA, Calif., Oct. 15, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) announced today that the U.S. Food and Drug Administration (FDA) has approved CustomSeal Technology...
September 18, 2014 08:00 ET | Source: TriVascular Technologies, Inc.

TriVascular, Inc. to Initiate Voluntary Field Safety Corrective Action for Certain Ovation Prime(R) Aortic Stent Grafts

SANTA ROSA, Calif., Sept. 18, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV), today announces it will initiate a voluntary field safety corrective action related to certain of...
September 12, 2014 13:00 ET | Source: TriVascular Technologies, Inc.

Three-Year Ovation(R) Pivotal Trial Data Presented at the 2014 Joint Annual Meeting of the New England Vascular Society and Eastern Vascular Society

SANTA ROSA, Calif., Sept. 12, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) presented three-year primary safety and performance metrics from the Ovation Pivotal Trial today at...
August 06, 2014 15:10 ET | Source: TriVascular Technologies, Inc.

TriVascular Technologies, Inc. Reports Second Quarter 2014 Financial Results

SANTA ROSA, Calif., Aug. 6, 2014 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (Nasdaq:TRIV) today reported financial results for the three and six months ended June 30, 2014. Recent...